Mankato Company and U of M Develop PRRS Vaccine

MINNESOTA - A Mankato-based company, along with researchers from the University of Minnesota, has developed a new pig vaccine that farmers and veterinarians are hoping will gradually obliterate PRRS, a disease that costs the industry more than $550 million a year.
calendar icon 26 May 2008
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.